Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Real World Use of Nucala in Severe Asthma Patients From the Severe Heterogenous Asthma Research Patient-centred Collaboration (SHARP)

NCT05441059 is registered in ClinicalTrials.gov with Frisius Medisch Centrum as lead sponsor.

NCT NCT05441059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05441059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Real World Use of Nucala in Severe Asthma Patients From the Severe Heterogenous Asthma Research Patient-centred Collaboration (SHARP)
Lead sponsor
Frisius Medisch Centrum
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
May 1, 2022
Enrollment
2,100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma severe persistent uncontrolled